Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome

Allogeneic stem cell transplantation may overcome the adverse impact of myelofibrosis on the prognosis of myelodysplastic syndrome

Abstract Purpose Myelofibrosis (MF) may serve as a poor prognostic factor in myelodysplastic syndromes (MDS). This study explored the impact of allogeneic hematopoietic stem cell transplantation (allo-HSCT) on the outcome of MDS patients with MF. Patients and Methods Three hundred and sixteen MDS pa...

Full description

Bibliographic Details
Main Authors: Xiangzong Zeng, Li Xuan, Zhiping Fan, Yu Zhang, Ke Zhao, Ya Zhou, Jun Xu, Qifa Liu, Min Dai
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Experimental Hematology & Oncology
Subjects:
Myelodysplastic syndrome
Myelofibrosis
Prognosis
Hematopoietic cell transplantation
Online Access:https://doi.org/10.1186/s40164-021-00238-x

Internet

https://doi.org/10.1186/s40164-021-00238-x

Similar Items